Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser

NCT01578421 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Renal Failure Chronic Requiring Hemodialysis

Interventions

DEVICE: 4 h online hemodiafiltration (FX 100, Polyflux 210, FXCorDiax)

Sponsor

Kantonsspital Aarau

Collaborators

[object Object]